Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

NCT05212103 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT05212103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
Lead sponsor
Turku University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2023
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, melanoma, non small cell lung cancer